By Ben Glickman
Stryker is set to report third-quarter results after the market closes Thursday. Here’s what you need to know:
NET INCOME: The Kalamazoo, Mich.-based medical technology company is expected to log a profit of $826.3 million, up from $816 million a year ago, according to the consensus of eight analysts polled by FactSet.
REVENUE: Stryker’s sales are forecast to rise to $4.87 billion, from $4.48 billion a year earlier, according to the estimates of 21 analysts polled by FactSet.
ADJUSTED EARNINGS: Stripping out certain one-time items, analysts expect Stryker to post earnings of $2.43 a share, according to FactSet.
WHAT TO WATCH
PROCEDURES: After second-quarter results, the company said positive procedural trends were leading to an improved sales outlook. Investors will be looking for signs that those trends have kept up.
ORTHOPEDICS: Stryker’s orthopedic segment maintained relatively strong revenue growth throughout the pandemic, especially when compared to peers. Investors will be looking for signs of where the orthopedic market is headed, and whether the strong revenue growth in the segment is likely to continue.
GUIDANCE: Analysts have seen Stryker’s guidance as somewhat conservative. If the medical technology company posts strong quarterly results, it may raise its outlook for the third time this year.
Write to Ben Glickman at ben.glickman@wsj.com
Read the full article here
